Wool-Like Hollow Polymeric Nanoparticles for CML Chemo-Combinatorial Therapy.

about

Wool-Like Hollow Polymeric Nanoparticles for CML Chemo-Combinatorial Therapy.

Item

http://www.wikidata.org/entity/Q52579601

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh-hant

name

Wool-Like Hollow Polymeric Nanoparticles for CML Chemo-Combinatorial Therapy.

@en

Wool-Like Hollow Polymeric Nanoparticles for CML Chemo-Combinatorial Therapy.

@nl

type

Item

label

Wool-Like Hollow Polymeric Nanoparticles for CML Chemo-Combinatorial Therapy.

@en

Wool-Like Hollow Polymeric Nanoparticles for CML Chemo-Combinatorial Therapy.

@nl

prefLabel

Wool-Like Hollow Polymeric Nanoparticles for CML Chemo-Combinatorial Therapy.

@en

Wool-Like Hollow Polymeric Nanoparticles for CML Chemo-Combinatorial Therapy.

@nl

P1476

Wool-Like Hollow Polymeric Nanoparticles for CML Chemo-Combinatorial Therapy

@en

P2093

Stefania D'Amone

http://www.w3.org/2001/XMLSchema#string

P2860

Quantitative analysis of dose-effect relationships: the combined effects of multiple drugs or enzyme inhibitors

Multiple BCR-ABL kinase domain mutations confer polyclonal resistance to the tyrosine kinase inhibitor imatinib (STI571) in chronic phase and blast crisis chronic myeloid leukemia

Clinical resistance to STI-571 cancer therapy caused by BCR-ABL gene mutation or amplification

Pathways of clathrin-independent endocytosis

Dynamics of three-dimensional replication patterns during the S-phase, analysed by double labelling of DNA and confocal microscopy.

Characterization of cancer stem cells in chronic myeloid leukaemia.

Combination of low-dose imatinib plus nilotinib for the treatment of chronic-phase chronic myeloid leukaemia after imatinib failure.

Coupled enzyme reactions in multicompartment microparticles.

Gelatin as a delivery vehicle for the controlled release of bioactive molecules.

Cytoplasmic delivery and nuclear targeting of synthetic macromolecules.

P31

scholarly article

P356

10.3390/PHARMACEUTICS10020052

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Ilaria E Palamà

Barbara Cortese

P577

2018-04-18T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29670043

http://www.w3.org/2001/XMLSchema#string

P932

6027521

http://www.w3.org/2001/XMLSchema#string